Innocare Pharma Limited Posted 14.2 Million Yuan Net Loss in First Quarter of 2023

Innocare Pharma Limited (诺诚健华医药有限公司) (688428.SH) reported a net loss of 14.2 million yuan in the first quarter of 2023, narrowing 88.2% year-on-year.

Meanwhile, the company posted 189.4 million yuan in revenue, up 59% year-on-year.

At the end of the reporting period, it had 10.2 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 25.9%.